Fox Chase Cancer Center, part of Philadelphia-based Temple Health, has been named the new home of the Robert A. Winn Excellence in Clinical Trials Award Program. The national program trains physicians and medical students to lead and improve access to clinical trials.
The Bristol Myers Squibb Foundation, which funded the program’s creation in 2020 with a $100 million commitment, has renewed its funding to support new cohorts of participants through 2030, according to a Nov. 16 news release from Fox Chase.
Gilead Sciences, Genentech, Amgen and AstraZeneca, the program’s other funders, will also continue their support. Since 2020, the program has funded 361 early-career physician investigators and 373 medical students.
The move follows Temple Health’s appointment of Robert Winn, MD, the program’s namesake, as cancer center director in March.
